Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
179474-79-4COCCCN1CCC(N)CC1HIXAJGFVNMKLML-UHFFFAOYSA-N179474-79-4DTXSID80477332Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H302: Harmful if swallowed [Warning Acute toxicity, oral];H312: Harmful in contact with skin [Warning Acute toxicity, dermal];H314: Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H412: Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
P260, P264, P270, P273, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P362+P364, P363, P405, and P501 (click each P-code to see the statement)
Danger
Acute Tox. 4 (100%);Acute Tox. 4 (100%);Skin Corr. 1B (100%);Aquatic Chronic 3 (100%)
Acute toxicity - category 4;Acute toxicity - category 4;Skin corrosion - category 1B;Hazardous to the aquatic environment (chronic) - category 3
Acute Tox. 4 *;Acute Tox. 4 *;Skin Corr. 1B;Aquatic Chronic 3
Verwenden1-(3-Methoxypropyl)-4-piperidinamine is a useful synthetic intermediate in the synthesis of Prucalopride Succinate (P838950); a selective 5-HT4 receptor agonist used effective for chronic constipation, but is not currently approved in the U.S. Prucalopride is approved for the treatment of chronic constipation in Europe.
Wird geladen…